The hospital sent a segment of the explanted material to atrium to be examined.The explanted segment was placed by the medical center inside a capped container and then placed inside multiple bio-hazard and polybags.Upon receipt by atrium medical, the returned segment was taken out of the capped bio-hazard container and placed inside a biohood to be examined.The returned segment was completely covered with blood and biological tissues.The explanted segment was about 1.5" in diameter.The initial visual inspection could not determine the presence of eptfe material due to the presence of thick layers of tissues.The explanted segment was then sent out to an independent lab for further analysis.The lab found that microscopically, the sample consisted of epidermis/dermis and associated subcuticular tissue (i.E., skin).Within the dermis there was a focally extensive area of dense, bundled collagen deposition interpreted to likely represent an area of surgical wound healing (i.E., ('scarification').Within the subcutis there was a focally extensive area of fibrovascular tissue proliferation (i.E., ('granulation tissue') associated with a fibrinous surface.This observation was interpreted as consistent with what would be expected to be surrounding/interfacing with a vascular graft implant.There was no evidence of non biological material (e.G., ptfe graft).The lot history of the referenced graft was reviewed and it was found to have met all specifications.An infection two years after the procedure is not likely to be caused by the graft.The product is provided sterile to the user.The sterilization records were reviewed and the sterilization load was processed within specifications.Conclusion: clinically removed material from the previous site of a vascular graft was consistent with reactive fibrous connective tissue with no evidence of non-biological material (e.G., ptfe graft material).
|